(Q41026046)

25 September 2017

Epidemiology of Acute Hepatitis B in the United States From Population-Based Surveillance, 2006-2011. (English)

1 reference

25 September 2017

3

Marion A Kainer

1 reference

25 September 2017

2

R Monina Klevens

1 reference

25 September 2017

8

Candace Vonderwahl

1 reference

25 September 2017

7

Kristin Sweet

1 reference

25 September 2017

6

Tasha Poissant

1 reference

25 September 2017

Kashif Iqbal

1

1 reference

25 September 2017

Jennifer Baumgartner

4

1 reference

25 September 2017

Kristin Gerard

5

1 reference

25 September 2017

Tracey Knickerbocker

9

1 reference

25 September 2017

Yury Khudyakov

10

1 reference

25 September 2017

Guo-Liang Xia

11

1 reference

25 September 2017

Henry Roberts

12

1 reference

25 September 2017

Eyasu Teshale

13

1 reference

25 September 2017

language of work or name

English

0 references

publication date

22 April 2015

1 reference

Clinical Infectious Diseases

25 September 2017

1 reference

25 September 2017

61

1 reference

25 September 2017

4

1 reference

25 September 2017

584-592

1 reference

The prevalence of hepatitis B virus infection in the United States in the era of vaccination

25 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Hepatitis B: Evolving Epidemiology and Implications for Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Projecting US primary care physician workforce needs: 2010-2025.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

"Never events": hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Outbreak of hepatitis B virus infections associated with assisted monitoring of blood glucose in an assisted living facility-Virginia, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

Harnessing electronic health records for public health surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV332

21 January 2018

Identifiers

DOI

10.1093/CID/CIV332

1 reference

release_tbkvjve4lnhkplh23b7i5frbgy

25 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tbkvjve4lnhkplh23b7i5frbgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference